Millendo Therapeutics

closed

Atterocor focuses on research and development of therapeutics for adrenal disease.

Launch date

2007

Employees

Market cap

Enterprise valuation

Company register number 497575621

Ann Arbor Michigan (HQ), Écully Auvergne-Rhône-Alpes (founding location)

Date	Investors	Amount	Round
-	Turenne Capital	N/A	-
Aug 2012	5AM Ventures Ann Arbor Spark Osage University Partners Frazier Healthcare Partners	$16.0m	Series A
Feb 2013	N/A	$8.5m	Growth Equity VC
Jan 2016	Adams Street Partners New Enterprise Associates 5AM Ventures Longwood Fund Renaissance Venture Capital Fund Osage University Partners Altitude Life Science Ventures Roche Venture Fund Frazier Healthcare Partners	$62.0m	Series B
Aug 2018	New Enterprise Associates	$30.0m	Late VC
Jun 2021	Tempest Therapeutics	N/A	Merger
Total Funding		€106m